(Q43136243)

English

A phase I study of oral panobinostat alone and in combination with docetaxel in patients with castration-resistant prostate cancer.

scientific article published on 9 March 2010

Statements

A phase I study of oral panobinostat alone and in combination with docetaxel in patients with castration-resistant prostate cancer (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit